TAP President Will Be Former Sales VP Alan MacKenzie
This article was originally published in The Pink Sheet Daily
Executive Summary
MacKenzie is rejoining TAP two months after being acquitted on charges of conspiracy to pay kickbacks to prescribers and defraud Medicaid in the U.S. government's investigation into Lupron marketing. Upon expiry of his term, current TAP President Thomas Watkins will rejoin Abbott in a senior management role.
You may also be interested in...
Human Genome Sciences CEO Is Former TAP President Thomas Watkins
Watkins joins HGS after serving as head of TAP Pharmaceuticals for six years. HGS focused its CEO search on candidates with late-stage product development experience; the firm's lead candidate LymphoStat-B is in Phase II for RA and lupus.
Bristol To Name New R&D Head Shortly
Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.